Odyssey Health, Inc. (ODYY): Entry into a Material Definitive Agreement
Odyssey Health, Inc. (ODYY) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement. On September 29, 2026, Odyssey Health, Inc., entered into Amendment No. 13 with LGH Investments, LLC. Pursuant to Amendment No. 13, the parties have agreed to extend the maturity date of the note to January 31, 2027. All othe
How this was made
The 30-second read
Why it matters
The extensions are a routine corporate action with limited immediate price effect.
Market read
A low‑impact filing that primarily informs existing and potential note holders; unlikely to drive trading activity.
What to watch
Potential hidden covenants or interest‑rate adjustments in the amendments that are not disclosed in the summary.
Background
SEC Form 8‑K filing by Odyssey Health, a micro‑cap biotech, detailing amendments to existing promissory notes.
Ticker impact
Odyssey Health filed an 8‑K reporting amendments that extend the maturity of two promissory notes to Jan 31 2027.
likely slight pressure as investors reassess the extended debt timeline
No new financing or covenant change; only maturity dates are pushed out, which typically does not move the stock materially.
Market effects
None; the amendment is specific to Odyssey Health and does not affect the broader healthcare sector.
No regional effect; the filing is company‑specific.
Minimal; the news is unlikely to influence global markets.
Counterpoint
If the extended maturities signal cash‑flow strain, the stock could face downside pressure.
Key entities
- companyOdyssey Health, Inc.
Issuer of the amended promissory notes.
- investorLGH Investments, LLC
Holder of one of the amended notes.
- investorPeter J. D’Arruda
Holder of the second amended note.
